Medicure Inc. (MPH)
TSXV
Closed
Oct 9, 2026
Day's Range
2.9752 wk Range
0.8500Overview - MPH - Medicure Inc.
Key Statistics
Valuation
Enterprise Value
29.44M
P/E (Trailing)
‪11.88‬
P/E (Forward)
‪-9.45‬
PEG Ratio
‪0.15‬
Price / Sales (TTM)
‪0.95‬
Price / Book
‪2.64‬
EV / EBITDA
‪-5.24‬
Profitability
Gross Margin
‪43.05%‬
Profit Margin
‪-23.22%‬
Operating Margin
‪-18.21%‬
Return on Assets
‪-17.77%‬
Return on Equity
‪-49.87%‬
Ownership
Shares Outstanding
10.43M
Float
5.22M
Short % of Shares Outstanding
‪0.05%‬
Held by Insiders
‪27.29%‬
Held by Institutions
‪23.09%‬
Price stats
Beta
‪1.15‬
50-Day Avg
‪2.04‬
200-Day Avg
‪1.37‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - MPH - Medicure Inc.
Peers - MPH - Medicure Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on TSXV.
Profile Summary - MPH - Medicure Inc.
About
Medicure Inc. is a pharmaceutical company engaged in the development and commercialization of therapeutics for the cardiovascular market. Its primary focus is on providing innovative and cost-effective therapies that improve the health outcomes of patients with cardiovascular diseases. This company is known for its…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
